Eclipsebio expands its RNA characterization capabilities with multi-attribute nanopore-based sequencing assay eSTRAND RNA QC™

Summary

Eclipsebio announced the expansion of its RNA characterization capabilities with the launch of eSTRAND RNA QC™, a nanopore-based sequencing assay that enables multi-attribute RNA analysis without requiring reverse transcription or translation.